Alcohol consumption, progression of disease and other comorbidities, and responses to antiretroviral medication in people living with HIV

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Neuman, Manuela G ^a,b,c   Schneider, Michelle ^d   Nanau, Radu M ^a,b   Parry, Charles ^d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b In Vitro Drug Safety and Biotechnology   (Canada)

^c Department of Pharmacology   (Canada)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870997863     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/751827     Document Type: Review

References (79)

1. Pithey A., Parry C., Descriptive systematic review of sub-Saharan African studies on the association between alcohol use and HIV infection. SAHARA-J 2009 6 4 155 169 2-s2.0-77649112667
2. Rehm J., Parry C. D., Alcohol consumption and infectious diseases in South Africa. The Lancet 2009 374 9707 2053 2-s2.0-72049100375 10.1016/S0140-6736(09)62150-4
3. Neuman M. G., Monteiro M., Rehm J., Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses. Substance Use and Misuse 2006 41 10-12 1395 1463 2-s2.0-33749151931 10.1080/10826080600846235 (Pubitemid 44472465)
4. Núñez M., Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. Journal of Hepatology 2006 44 1 S132 S139 2-s2.0-30144435244 10.1016/j.jhep.2005.11.027 (Pubitemid 43053889)
5. Barve S., Kapoor R., Moghe A., Ramirez J. A., Eaton J. W., Gobejishvili L., Joshibarve S., Mcclain C. J., Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV infected patients. Alcohol Research and Health 2010 33 3 229 236 2-s2.0-78549296365
6. Rehm J., Samokhvalov A. V., Neuman M. G., Room R., Parry C., Lönnroth K., Patra J., Poznyak V., Popova S., The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009 9, article 450 2-s2.0-73449109188 10.1186/1471-2458-9-450
7. Quintero D., Guidot D. M., Focus on the lung. Alcohol Research and Health 2010 33 3 219 228 2-s2.0-78549288125
8. Freiberg M. S., Kraemer K. L., Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease. Alcohol Research and Health 2010 33 3 237 246 2-s2.0-78549257064
9. Rosenbloom M. J., Sullivan E. V., Pfefferbaum A., Focus on the brain: HIV infection and alcoholism comorbidity effects on brain structure and function. Alcohol Research and Health 2010 33 3 247 257 2-s2.0-78549267784
10. Lieber C. S., Alcohol and the liver: 1994 update. Gastroenterology 1994 106 4 1085 1105 2-s2.0-0028350768 (Pubitemid 24109299)
11. Chaudhry A. A., Sulkowski M. S., Chander G., Moore R. D., Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort. HIV Medicine 2009 10 3 133 142 2-s2.0-61349155565 10.1111/j.1468-1293.2008.00662.x
12. Vecchi V. L., Soresi M., Colomba C., Mazzola G., Colletti P., Mineo M., di Carlo P., la Spada E., Vizzini G., Montalto G., Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients. World Journal of Gastroenterology 2010 16 41 5225 5232 2-s2.0-78649403795 10.3748/wjg.v16.i41.5225
13. Rosenthal E., Pialoux G., Bernard N., Pradier C., Rey D., Bentata M., Michelet C., Pol S., Perronne C., Cacoub P., Liver-related mortality in human-immunodeficiency-virusinfected patients between 1995 and 2003 in the French GERMIVIC joint study group network (MORTAVIC 2003 study). Journal of Viral Hepatitis 2007 14 3 183 188 2-s2.0-33846991954 10.1111/j.1365-2893.2006. 00791.x
14. Rosenthal E., Salmon-Céron D., Lewden C., Bouteloup V., Pialoux G., Bonnet F., Karmochkine M., May T., François M., Burty C., Jougla E., Costagliola D., Morlat P., Chêne G., Cacoub P., Pautard-Huchemblé B., Schmit J. L., Bonnefoy M., Bru J. P., Gaillat J., Lerousseau L., Dubois D., Azzedine A., De La Blanchardière A., Lepeu G., Faller J. P., Balvay P., Barale F., Estavoyer J. M., Vuitton D., Bentata M., Cohen P., Guillevin L., Jarrousse B., Padrazzi B., Beylot J., Bernard N., Constans J., Loury I., Moreau F., Morlat P., Ragnaud J. M., Viaud J. F., Lacoste D., Baglin A., Dorra M., Dupont C., Hanslik T., Rouveix E., Granier P., Cénac A., Bazin C., Hazera P., Verdon R., Schmidt J., Rogeaux O., Menalba C., Boué F., Fior R., Galanaud P., Pik J. J., Beytout J., Laurichesse H., Ruivard M., Laplatte G., Audoy B., Plaisance N., Bouterra C., Laylotte G., Delarocque E., Vinceneux P., Lesprit P., Schaeffer A., Grappin M., Greuzard M. C., Loudes-Chauvin M. C., Portier H., Vinceneux M., Guillaumie J., Dournovo P., De Truchis P., Perronne C., Bouchard O., Micoud M., Morand P., Boucher J., Chambourlier P., Renou C., Arvin-Berod C., Poubeau P., Perre P., Hachulla E., Devulder B., Hatron P. Y., Loustaud-Ratti V., Berthou J. D., Baborier D., Constant E., Dufay E., Peyramond D., Trémolières F., Bourgeade A., Durand J. M., Gastaut J. A., Gallais H., Moreau J., Perret J. L., Poizot-Martin I., Soubeyrand J., Meissonnier P., Hayek R., Constant C., Raabe J. J., Wang A., Astruc J., Blanc F., Perney P., Vandôme A., Bautoille D., Guerbois C., Loyau C., Raffi F., Villers D., Burty C., Canton P., de Korwin J. D., Thibaut G., Wahl D., Dellamonica P., Cassuto J. P., Ceppi C., Fuzibet J. G., Poirée M., Pradier C., Rosenthal E., Raffanel C., Amoura Z., Aumaitre H., Bani-Sadr F., Bissuel F., Boissonnas A., Bouvet E., Bricaire F., Cabane J., Cabié A., Cacoub P., Caquet R., Carbon C., Caulin C., Chemlal K., Coulaud J. P., de Beaumont T., Devars du Mayne F., Dupont C., Durand B., Farge D., Galanaud P., Gaudebout C., Gilquin J., Goujard C., Hausfater P., Katlama C., Karmochkine M., Krainik F., Le Bras P., Le Moing V., Leport C., Modaï J., Molina J. M., Pialoux G., Piette J. C., Poinsignon Y., Quertainmont Y., Raguin G., Rozenbaum W., Sicard D., Simon J., Vachon F., Valleron A. J., Vildé J. L., Arsac P., Calamy G., Mille C., Mercie P., Pellegrin J. L., Becq-Giraudon B., Breux J. P., Le Moal G., Michelet C., Cartier F., Beguinot I., Rémy G., Gueit I., Borsa-Lebas F., Humbert G., Wemeau J., Hascouet C., Le Cam B., Khuong M. A., Roblin X., Defontaine C., Lucht F., Fégueux S., Veyssier-Belot C., Ouzan D., Kitschke B., Clément-Bertoldo C., Gonzales G., Poubeau P., Fischer P., Lang J. M., Rey D., Ruellan A., Schlienger J. L., Zucman D., Blétry O., Romand P., Alric L., Cuzin L., Duffaut M., Ajana F., Mouton Y., Yazdanpanah Y., Borderon J. C., Choutet P., Guimard Y., Patey O., Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalité 2005 survey, ANRS EN19). HIV Medicine 2009 10 5 282 289 2-s2.0-65549114917 10.1111/j.1468-1293.2008.00686.x
15. Pol S., Lamorthe B., Thi N. T., Thiers V., Carnot F., Zylberberg H., Berthelot P., Bréchot C., Nalpas B., Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. Journal of Hepatology 1998 28 6 945 950 2-s2.0-0032101819 10.1016/S0168-8278(98)80341-3 (Pubitemid 28275971)
16. Castellares C., Barreiro P., Martín-Carbonero L., Labarga P., Vispo M. E., Casado R., Galindo L., García-Gascó P., García-Samaniego J., Soriano V., Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. Journal of Viral Hepatitis 2008 15 3 165 172 2-s2.0-38449120595 10.1111/j.1365-2893.2007.00903.x (Pubitemid 351143738)
17. Lana R., Núñez M., Mendoza J. L., Soriano V., Rate and risk factors of liver toxicity in patients receiving antiretroviral therapy. Medicina Clinica 2001 117 16 607 610 2-s2.0-0035904752 (Pubitemid 33123297)
18. Neuman M. G., Cytokines-central factors in alcoholic liver disease. Alcohol Research and Health 2003 27 4 307 316 2-s2.0-16544370740 (Pubitemid 40685570)
19. Neuman M. G., Apoptosis in diseases of the liver. Critical Reviews in Clinical Laboratory Sciences 2001 38 2 109 166 2-s2.0-0035035052 (Pubitemid 32391858)
20. Míguez-Burbano M. J., Lewis J. E., Malow R., Alcohol and race/ethnicity elicit different changes in lipid profiles in HIV-infected individuals receiving highly active antiretroviral therapy. Journal of the Association of Nurses in AIDS Care 2009 20 3 176 183 2-s2.0-65449188336 10.1016/j.jana.2009.02.004
21. M. Murdoch D., Napravnik S., Eron J. J. Jr., van Rie A., Smoking and predictors of pneumonia among HIV-infected patients receiving care in the HAART era. The Open Respiratory Medicine Journal 2008 2 22 28
22. Grau I., Pallares R., Tubau F., Schulze M. H., Llopis F., Podzamczer D., Liñares J., Gudiol F., Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Archives of Internal Medicine 2005 165 13 1533 1540 2-s2.0-23044454558 10.1001/archinte.165.13.1533 (Pubitemid 41058035)
23. Corral I., Quereda C., Moreno A., Pérez-Elías M. J., Dronda F., Casado J. L., Muriel A., Masjuán J., Alonso-De-Leciñana M., Moreno S., Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovascular Diseases 2009 27 6 559 563 2-s2.0-65449165315 10.1159/000214219
24. Ellis R. J., Rosario D., Clifford D. B., McArthur J. C., Simpson D., Alexander T., Gelman B. B., Vaida F., Collier A., Marra C. M., Ances B., Atkinson J. H., Dworkin R. H., Morgello S., Grant I., Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Archives of Neurology 2010 67 5 552 558 2-s2.0-77952121864 10.1001/archneurol. 2010.76
25. Baum M. K., Rafie C., Lai S., Sales S., Page J. B., Campa A., Alcohol use accelerates HIV disease progression. AIDS Research and Human Retroviruses 2010 26 5 511 518 10.1089/aid.2009.0211
26. Fama R., Eisen J. C., Rosenbloom M. J., Sassoon S. A., Kemper C. A., Deresinski S., Pfefferbaum A., Sullivan E. V., Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity. Alcoholism: Clinical & Experimental Research 2007 31 6 1038 1044 2-s2.0-34248667014 10.1111/j.1530-0277.2007.00385.x (Pubitemid 46776171)
27. Fama R., Rosenbloom M. J., Nichols B. N., Pfefferbaum A., Sullivan E. V., Working and episodic memory in HIV infection, alcoholism, and their comorbidity: baseline and 1-year follow-up examinations. Alcoholism: Clinical & Experimental Research 2009 33 10 1815 1824 2-s2.0-70349311754 10.1111/j.1530-0277.2009.01020.x
28. Madeddu G., Porqueddu E. M., Cambosu F., Saba F., Fois A. G., Pirina P., Mura M. S., Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era. Infection 2008 36 3 231 236 2-s2.0-45849148857 10.1007/s15010-007-7162-0
29. Crum-Cianflone N., Collins G., Medina S., Asher D., Campin R., Bavaro M., Hale B., Hames C., Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons. Clinical Gastroenterology and Hepatology 2010 8 2 183 191 2-s2.0-75349083385 10.1016/j.cgh.2009.09.025
30. Loko M. A., Salmon D., Carrieri P., Winnock M., Mora M., Merchadou L., Gillet S., Pambrun E., Delaune J., Valantin M. A., Poizot Martin I., Neau D., Bonnard P., Rosenthal E., Barange K., Morlat P., Lacombe K., Gervais A., Rouges F., Bicart See A., Lascoux-Combe C., Vittecoq D., Goujard C., Duvivier C., Spire B., Izopet J., Sogni P., Serfaty L., Benhamou Y., Bani-Sadr F., Dabis F., The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infectious Diseases 2010 10, article 303 2-s2.0-77958028550 10.1186/1471-2334-10-303
31. Henrich T. J., Lauder N., Desai M. M., Sofair A. N., Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. Journal of Community Health 2008 33 2 69 77 2-s2.0-39149088032 10.1007/s10900-007-9069-1
32. Pol S., Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS 1996 10 11 1293 1294 2-s2.0-0029839741 (Pubitemid 26306612)
33. Miguez M. J., Shor-Posner G., Morales G., Rodriguez A., Burbano X., HIV treatment in drug abusers: impact of alcohol use. Addiction Biology 2003 8 1 33 37 2-s2.0-0037358499 10.1080/1355621031000069855 (Pubitemid 36433977)
34. Samet J. H., Cheng D. M., Libman H., Nunes D. P., Alperen J. K., Saitz R., Alcohol consumption and HIV disease progression. Journal of Acquired Immune Deficiency Syndromes 2007 46 2 194 199 2-s2.0-34547781092 10.1097/QAI. 0b013e318142aabb (Pubitemid 47482615)
35. Baum M. K., Rafie C., Lai S., Sales S., Page J. B., Campa A., Alcohol use accelerates HIV disease progression. AIDS Research and Human Retroviruses 2010 26 5 511 518 2-s2.0-77952561522 10.1089/aid.2009.0211
36. Shacham E., Agbebi A., Stamm K., Overton E. T., Alcohol consumption is associated with poor health in HIV clinic patient population: a behavioral surveillance study. AIDS and Behavior 2009 15 1 209 213 2-s2.0-71649084784 10.1007/s10461-009-9652-9
37. Míguez-Burbano M. J., Lewis J. E., Fishman J., Asthana D., Malow R. M., The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome. Alcohol and Alcoholism 2009 44 4 366 371 2-s2.0-67650233331 10.1093/alcalc/agp024
38. Hessol N. A., Kalinowski A., Benning L., Mullen J., Young M., Palella F., Anastos K., Detels R., Cohen M. H., Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clinical Infectious Diseases 2007 44 2 287 294 2-s2.0-33846174644 10.1086/510488 (Pubitemid 46079997)
39. Braithwaite R. S., Conigliaro J., Roberts M. S., Shechter S., Schaefer A., McGinnis K., Rodriguez M. C., Rabeneck L., Bryant K., Justice A. C., Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care 2007 19 4 459 466 2-s2.0-34247115898 10.1080/09540120601095734 (Pubitemid 46598742)
40. Robbins G. K., Johnson K. L., Chang Y., Jackson K. E., Sax P. E., Meigs J. B., Freedberg K. A., Predicting virologic failure in an HIV clinic. Clinical Infectious Diseases 2010 50 5 779 786 2-s2.0-76749144117 10.1086/650537
41. Hendershot C. S., Stoner S. A., Pantalone D. W., Simoni J. M., Alcohol use and antiretroviral adherence: review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes 2009 52 2 180 202 2-s2.0-70349662284 10.1097/QAI.0b013e3181b18b6e
42. Naar-King S., Arfken C., Frey M., Harris M., Secord E., Ellis D., Psychosocial factors and treatment adherence in paediatric HIV/AIDS. AIDS Care 2006 18 6 621 628 2-s2.0-33745887185 10.1080/09540120500471895 (Pubitemid 44050520)
43. Finucane M. M., Samet J. H., Horton N. J., Translational methods in biostatistics: linear mixed effect regression models of alcohol consumption and HIV disease progression over time. Epidemiologic Perspectives and Innovations 2007 4, article 8 2-s2.0-37349048177 10.1186/1742-5573-4-8 (Pubitemid 350293846)
44. Lazo M., Gange S. J., Wilson T. E., Anastos K., Ostrow D. G., Witt M. D., Jacobson L. P., Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clinical Infectious Diseases 2007 45 10 1377 1385 2-s2.0-36048955893 10.1086/522762 (Pubitemid 351411918)
45. Sankar A., Wunderlich T., Neufeld S., Luborsky M., Sero-positive African Americans' beliefs about alcohol and their impact on anti-retroviral adherence. AIDS and Behavior 2007 11 2 195 203 2-s2.0-33847321985 10.1007/s10461-006-9144-0
46. Sullivan P. S., Campsmith M. L., Nakamura G. V., Begley E. B., Schulden J., Nakashima A. K., Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE 2007 2 6 e552 2-s2.0-38849156855 10.1371/journal.pone.0000552 (Pubitemid 351194007)
47. Leserman J., Ironson G., O'Cleirigh C., Fordiani J. M., Balbin E., Stressful life events and adherence in HIV. AIDS Patient Care and STDs 2008 22 5 403 411 2-s2.0-44349179134 10.1089/apc.2007.0175 (Pubitemid 351733239)
48. Parsons J. T., Rosof E., Mustanski B., Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders. AIDS and Behavior 2008 12 1 95 103 2-s2.0-38449103806 10.1007/s10461-007-9241-8 (Pubitemid 351143452)
49. Plankey M., Bacchetti P., Jin C., Grimes B., Hyman C., Cohen M., Howard A. A., Tien P. C., Self-perception of body fat changes and HAART adherence in the women's interagency HIV study. AIDS and Behavior 2009 13 1 53 59 2-s2.0-58149083834 10.1007/s10461-008-9444-7
50. Applebaum A. J., Richardson M. A., Brady S. M., Brief D. J., Keane T. M., Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder. AIDS and Behavior 2009 13 1 60 65 2-s2.0-58149086731 10.1007/s10461-008-9441-x
51. Arasteh K., Des Jarlais D. C., HIV testing and treatment among at-risk drinking injection drug users. Journal of the International Association of Physicians in AIDS Care 2009 8 3 196 201 2-s2.0-68149131462 10.1177/ 1545109709336222
52. Kalichman S. C., Amaral C. M., White D., Swetsze C., Pope H., Kalichman M. O., Cherry C., Eaton L., Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care and STDs 2009 23 6 449 454 2-s2.0-67651158958 10.1089/apc.2008.0184
53. Kavasery R., Galai N., Astemborski J., Lucas G. M., Celentano D. D., Kirk G. D., Mehta S. H., Nonstructured treatment interruptions among injection drug users in Baltimore, MD. Journal of Acquired Immune Deficiency Syndromes 2009 50 4 360 366 2-s2.0-64249167491 10.1097/QAI.0b013e318198a800
54. Lillie-Blanton M., Stone V. E., Snow Jones A., Levi J., Golub E. T., Cohen M. H., Hessol N. A., Wilson T. E., Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005. American Journal of Public Health 2010 100 8 1493 1499 2-s2.0-77954515280 10.2105/AJPH.2008.158949
55. Lehavot K., klehavot@u.washington.edu Huh D., Walters K. L., King K. M., Andrasik M. P., Simoni J. M., Buffering effects of general and medication-specific social support on the association between substance use and HIV medication adherence. AIDS Patient Care and STDs 2011 25 3 181 189 10.1089/apc.2010.0314
56. Spire B., Duran S., Souville M., Leport C., Raffi F., Moatti J. P., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Social Science and Medicine 2002 54 10 1481 1496 2-s2.0-0036222752 10.1016/S0277-9536(01)00125-3 (Pubitemid 34309013)
57. Roux P., Carrieri M. P., Villes V., Dellamonica P., Poizot-Martin I., Ravaux I., Spire B., The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008 103 11 1828 1836 2-s2.0-54049149928 10.1111/j.1360-0443.2008.02323.x
58. Protopopescu C., Raffi F., Roux P., Reynes J., Dellamonica P., Spire B., Leport C., Carrieri M. P., Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. Journal of Antimicrobial Chemotherapy 2009 64 3 599 606 2-s2.0-69049118182 10.1093/jac/dkp232
59. Michel L., Carrieri M. P., Fugon L., Roux P., Aubin H. J., Lert F., Obadia Y., Spire B., Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care 2010 22 9 1136 1145 2-s2.0-77956465196 10.1080/09540121003605039
60. Glass T. R., Battegay M., Cavassini M., De Geest S., Furrer H., Vernazza P. L., Hirschel B., Bernasconi E., Rickenbach M., Günthard H. F., Bucher H. C., Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: swiss HIV cohort study. Journal of Acquired Immune Deficiency Syndromes 2010 54 2 197 203 2-s2.0-77953040583 10.1097/QAI.0b013e3181ca48bf
61. Södergård B., Halvarsson M., Tully M. P., Mindouri S., Nordström M. L., Lindbäck S., Sönnerborg A., Lindblad A.K., Adherence to treatment in Swedish HIV-infected patients. Journal of Clinical Pharmacy and Therapeutics 2006 31 6 605 616 2-s2.0-33751366819 10.1111/j.1365-2710.2006.00782.x (Pubitemid 44813773)
62. Grierson J., j.grierson@latrobe.edu.au Koelmeyer R. L., Smith A., Pitts M., Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Medicine 2011 12 9 562 569 10.1111/j.1468-1293. 2011.00928.x
63. Nachega J. B., Knowlton A. R., Deluca A., Schoeman J. H., Watkinson L., Efron A., Chaisson R. E., Maartens G., Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study. Journal of Acquired Immune Deficiency Syndromes 2006 43, supplement 1 S127 S133 2-s2.0-33845354317 10.1097/01.qai.0000248349.25630.3d (Pubitemid 44885652)
64. Fitzgerald M., Collumbien M., Hosegood V., No one can ask me Why do you take that stuff?: men's experiences of antiretroviral treatment in South Africa. AIDS Care 2010 22 3 355 360 2-s2.0-77951062856 10.1080/09540120903111536
65. Jaspan H. B., hbjaspan@gmail.com Mueller A. D., Myer L., Bekker L.-G., Orrell C., Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa. AIDS Patient Care and STDs 2011 25 10 595 600 10.1089/apc.2010.0323
66. Manfredi R., roberto.manfredi@unibo.it Calza L., HIV infection and the pancreas: risk factors and potential management guidelines. International Journal of STD & AIDS 2008 19 2 99 105 10.1258/ijsa.2007.007076 (Pubitemid 351738814)
67. Beyene K. A., Gedif T., Gebre-Mariam T., Engidawork E., Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia. Pharmacoepidemiology and Drug Safety 2009 18 11 1007 1015 2-s2.0-70549103497 10.1002/pds.1814
68. Do N. T., Phiri K., Bussmann H., Gaolathe T., Marlink R. G., Wester C. W., Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Research and Human Retroviruses 2010 26 6 685 691 2-s2.0-77954196309 10.1089/aid.2009.0222
69. Jaquet A., Ekouevi D. K., Bashi J., Aboubakrine M., Messou E., Maiga M., Traore H. A., Zannou M. D., Guehi C., Ba-Gomis F. O., Minga A., Allou G., Eholie S. P., Bissagnene E., Sasco A. J., Dabis F., Alcohol use and non-adherence to antiretroviral therapy in HIV-infected patients in West Africa. Addiction 2010 105 8 1416 1421 2-s2.0-77954469388 10.1111/j.1360-0443.2010.02978.x
70. Bonolo P. D. F., César C. C., Acúrcio F. A., Ceccato M. D. G. B., Menezes De Pádua C. A., Álvares J., Campos L. N., Carmo R. A., Guimarães M. D. C., Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil. AIDS 2005 19, supplement 4 S5 S13 2-s2.0-27944489164 (Pubitemid 41668980)
71. De Fátima Bonolo P., Machado C. J., César C. C., Ceccato M. D. G. B., Guimarães M. D. C., Vulnerability and non-adherence to antiretroviral therapy among HIV patients, Minas Gerais State, Brazil. Cadernos de Saude Publica 2008 24 11 2603 2613 2-s2.0-56349154921
72. Kitkungvan D., Apisarnthanarak A., Laowansiri P., Mundy L. M., Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense. HIV Medicine 2008 9 8 636 641 2-s2.0-52649126831 10.1111/j.1468-1293.2008.00611.x
73. Venkatesh K. K., Srikrishnan A. K., Mayer K. H., Kumarasamy N., Raminani S., Thamburaj E., Prasad L., Triche E. W., Solomon S., Safren S. A., Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care and STDs 2010 24 12 795 803 2-s2.0-78650078710 10.1089/apc.2010.0153
74. Neblett R. C., rneblet1@jhmi.edu Hutton H. E., Lau B., McCaul M. E., Moore R. D., Chander G., Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. Journal of Women's Health 2011 20 2 279 286 10.1089/jwh.2010.2043
75. Halkitis P. N., Kutnick A. H., Slater S., The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states. Journal of Health Psychology 2005 10 4 545 558 2-s2.0-22344432685 10.1177/1359105305053422 (Pubitemid 41003389)
76. Smith C. J., Levy I., Sabin C. A., Kaya E., Johnson M. A., Lipman M. C. I., Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population. HIV Medicine 2004 5 2 88 92 2-s2.0-1642565262 10.1111/j.1468-1293.2004.00191.x (Pubitemid 38404661)
77. Kigozi I. M., Dobkin L. M., Martin J. N., Geng E. H., Muyindike W., Emenyonu N. I., Bangsberg D. R., Hahn J. A., Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes 2009 52 2 280 289 2-s2.0-70349690548 10.1097/QAI.0b013e3181ab6eab
78. Gardner E. M., Burman W. J., Steiner J. F., Anderson P. L., Bangsberg D. R., Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS 2009 23 9 1035 1046 2-s2.0-67651085608 10.1097/QAD.0b013e32832ba8ec
79. Shuper P. A., Neuman M., Kanteres F., Baliunas D., Joharchi N., Rehm J., Causal considerations on alcohol and HIV/AIDS-a systematic review. Alcohol and Alcoholism 2010 45 2 159 166 2-s2.0-77949372144 10.1093/alcalc/agp091